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ABSTRACT

Weiss, Jessica A. M.S., Purdue University, August 2016. Effect of Obesity on the
Skeletal Muscle Angiogenic Response Following Acute Resistance Exercise. Major
Professor: Timothy Gavin.

With the rates of obesity remaining high, health risks are abundant. This includes
an increased possibility of the development of insulin resistance and type 2 diabetes
mellitus (T2DM). Several biochemical and histochemical characteristics associated with
obesity have been reported, including a reduction in capillary density in the skeletal
muscle and increased muscle fiber size. Resistance exercise is known to induce
hypertrophy and increase skeletal muscle capillarization. Following acute resistance
exercise, it is hypothesized angiogenic factors are reduced and angiostatic factors are
increased in the skeletal muscle of obese individuals. Muscle biopsies from the vastus
lateralis were obtained to investigate whether VEGF, VEGF receptor, TSP-1 expression,
and AMPK phosphorylation (an indicator AMPK activation) are lower in obese
compared to lean individuals at rest and in response to an acute bout of exercise. Muscle
biopsies were taken before, 15 MIN, and 3 HR following 3 sets of single-leg knee
extension at 80% 1 RM. Eight sedentary lean (4 male, 4 female) and eight sedentary
obese (4 male, 4 female) individuals participated in this study. No differences in VEGF
or VEGF receptor mRNA and protein levels were found at rest or following exercise in
lean or obese individuals. Exercise increased VEGF mRNA independent of group.
Resistance exercise did not affect TSP-1 mRNA and protein expression or AMPK
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phosphorylation and no differences between lean and obese were found. The present
study suggests that the angiogenic response to resistance exercise (a known hypertrophic
stimulus) is similar in lean and obese individuals.

1

CHAPTER 1. INTRODUCTION

Obesity and Insulin Resistance
The prevalence of obesity in the United States remains high, with 78.6 million
adults currently falling under this classification (Centers for Disease Control and
Prevention, 2014). Many chronic conditions are associated with obesity, which has
earned it the title of the second leading cause of preventable death in the United States by
the National Heart, Lung, and Blood Institute (NHLBI). Health problems associated with
obesity include hypertension, heart disease, metabolic syndrome, and type 2 diabetes
mellitus (T2DM) (Mayo Clinic, 2015). In 2008, the estimated annual medical cost of
obesity in the United States was $147 billion and has been projected to rise due to the
increasing prevalence of T2DM (Centers for Disease Control and Prevention, 2014).
According to the National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK), T2DM frequently is the result of prolonged insulin resistance or a decreased
sensitivity and/or responsiveness to insulin. Insulin resistance is common among the
obese population. It is estimated that 24% of obese adults in the United States are insulin
resistant while in the obese adolescent population prevalence is estimated at 52% (Lee et
al, 2006; McKeown et al, 2004).
The human body consists of roughly 40% skeletal muscle, which is responsible
for 75% of insulin-induced glucose disposal (Reaven & Laws, 1999).
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Several biochemical and histochemical characteristics within the skeletal muscle have
been associated with obesity. Studies have shown fiber type dissimilarities between the
skeletal muscles of lean compared to obese individuals. A decrease in Type I, slow twitch
oxidative, fibers concurrent with an increase in Type IIB, fast twitch glycolytic, fibers has
been noted in obese individuals (Lillioja et al, 1987). The area of skeletal muscle fibers of
obese individuals is significantly larger than the skeletal muscle fibers of lean individuals
(Gavin et al, 2005). Reduced mitochondrial function, reducing the oxidative capacity of
the skeletal muscle, has also been reported in obese individuals (Torgan et al, 1989).
Primarily, obesity has been strongly correlated to a reduction in capillary density, or the
number of capillaries per unit cross-sectional area of muscle (Gavin et al, 2005; Lash et
al, 1989; Lillioja et al, 1987; Shono et al, 1999; Torgan et al, 1989). Capillaries are
essential for the delivery of oxygen and other nutrients important for energy production.
Increased capillarization ensures adequate diffusion capacity across the skeletal muscle
(Hudlicka, Brown & Egginton, 1992). Therefore, alterations in skeletal muscle
capillarization may contribute to much of the insulin resistance associated with obesity
(Lillioja et al, 1987; Shono et al, 1999).

The Impact of Exercise
Exercise has been proven to be beneficial to overall health in a variety of ways.
Those who participate in physical activity for 7 hours or more a week reduce their risk of
mortality by 40% (Centers for Disease Control and Prevention, 2015). It has been wellestablished that endurance training provides many improvements to overall health. A host
of effects of aerobic exercise support improvements which include cardiac and skeletal
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muscle changes. Adaptations in skeletal muscle include increases in mitochondrial
content, respiratory capacity, and capillary density of muscle fibers (Andersen &
Henriksson, 1977; Hermansen & Wachtlova, 1971; Holloszy & Coyle, 1984; Yamashita
et al, 1993). Regular resistance exercise can also improve cardiovascular, bone, and
muscle health and reduce the risks of many chronic diseases (American College of Sports
Medicine Position Stand, 1990). Muscle hypertrophy observed with resistance exercise
contributes to an increase in muscle strength, basal metabolic rate, and lean body mass,
while decreasing body fat composition. Resistance exercise has also been shown to
benefit glucose metabolism, lowering basal insulin levels and increasing insulin
sensitivity (Pollock & Vincent, 1996). Less recognized as an outcome of resistance
exercise is an increase in skeletal muscle capillarization (McCall et al, 1996; Schantz,
1982). Increased capillary density improves the exchange of oxygen, substrates, and
metabolites between blood and skeletal muscle (Andersen & Henriksson, 1977;
Hermansen & Wachtlova, 1971; Poole, Copp, Ferguson, & Musch, 2013; Tesch,
Thorsson & Kaiser, 1984), which is vitally important for individuals with chronic
conditions where this exchange has been compromised (Adair & Montani, 2010).

Skeletal Muscle Angiogenesis
Angiogenesis, the process of generating new capillary blood vessels, occurs in
response to signals from changes in mechanical stimuli and metabolic demand (Hudlicka,
Brown & Egginton, 1992). It involves a complex cascade of events leading to the
migration and proliferation of capillary endothelial cells (EC) (Engerman et al, 1967).
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The interplay of both angiogenic (positive) and angiostatic (negative) factors contribute
to this process.
Angiogenic and Angiostatic Factors
One of the most vital pro-angiogenic factors for basal and exercise-induced
capillarization is vascular endothelial growth factor (VEGF). VEGF is a 45 kDa heparinbinding vascular EC mitogen of the micro- and macrovascular EC of arteries, veins, and
the lymphatics (Amaral et al, 2001; Dvorak et al, 1979; Ferrara & Davis-Smyth, 1997;
Ferrara & Henzel, 1989; Gavin TP, 2009; Olfert et al, 2009; Tang et al, 2004; Wagner et
al, 2006). Although several different isoforms exists, VEGF-A plays the most crucial role
in exercise-induced skeletal muscle angiogenesis (Shweiki et al, 1992; Waltenberger et
al, 1994). It is released into the muscle interstitial space in response to mechanical stimuli
and other stress inducing factors (Gavin et al, 2007; Hoffner, Nielsen, Langberg, &
Hellsten, 2003; Hoier et al, 2011; Hoier et al, 2012; Hoier et al, 2010; Ouchi, Shibata, &
Walsh, 2005), including hypoxia, oxidative stress, growth factors, and cytokines (Ikeda et
al, 1995; Kuroki et al, 1996; Takahashi et al, 2002; Wang, Huang, Kazlauskas, &
Cavenee, 1999).
Two receptors identified as having a high affinity for VEGF are VEGFR1 (de Vries
et al, 1992) and VEGFR2. Expression of both receptors is restricted to the vascular
endothelium, where the positive charge of the surface of VEGF facilitates its binding
(Ferrara & Keyt, 1997; Keyt et al, 1996; Yamaguchi et al, 1993). VEGFR2 is suggested
to be the receptor principally involved in angiogenesis (Millauer et al, 1993; Gavin TP,
2009; Waltenberger et al, 1994). The phosphorylation of VEGFR2 initiates several
signaling cascades, resulting in increased vascular permeability and the migration,
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proliferation, and survival of EC (Connolly et al, 1989; Koch et al, 2011). One important
cascade involves VEGFR2 activation of endothelial nitric oxide synthase (eNOS) to
produce nitric oxide (NO) which in turn stimulates EC growth and motility (Ziche et al,
1994). The NO cascade activated by VEGFR2 phosphorylation is inhibited by
thrombospondin-1 (TSP-1) (Isenberg et al, 2006).
TSP-1 is a 450 kDa multifunctional homotrimeric matrix glycoprotein that is
thought to play an important role in the regulation of angiogenesis (Iruela-Arispe et al,
1995; Lawler, Slayter, & Coligan, 1978). Though TSP-1 has been shown to stimulate the
growth and migration of smooth muscle cells (BenEzra, Griffin, Maftzir, & Aharonov,
1993; Lawler, 2000; Nicosia & Tuszynski, 1994). It prevents angiogenesis via inhibition
of VEGF release, VEGF signal transduction, and by direct interaction with VEGF
(Iruela-Arispe, Bornstein, & Sage, 1991; Lawler & Lawler, 2012). VEGF bioavailability
is decreased due to the influence of TSP-1 on the structure of the extracellular matrix
(Iruela-Arispe et al, 1995; Lawler, 1986; Chen, Herndon, & Lawler, 2000). TSP-1
binding to receptors CD36 and CD47 inhibits VEGFR2 phosphorylation (Primo et al,
2005), which hinders EC association at the site of development (Bagavandoss & ilks,
1990; Dawson et al, 1997), migration of EC, and stimulates apoptosis (Iruela-Arispe,
Bornstein, & Sage, 1991). Further, the uptake and clearance of VEGF from the
extracellular space is induced by TSP-1 binding directly to VEGF (Gupta et al, 1999;
Greenaway et al, 2007; Lawler & Lawler, 2012). Consistent with TSP-1 being an
angiostatic factor, skeletal muscle capillarization is lower in TSP-1 knock-out (KO)
compared to wildtype (WT) mice (Malek & Olfert, 2009).
Intracellular Regulation
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A key player in the regulation of the responses to angiogenesis-inducing stressors is
the heterotrimeric enzyme 5’-AMP-activated protein kinase (AMPK) (Hardie, 2003).
When two molecules of adenosine diphosphate (ADP) are used to produce energy in the
form of adenosine triphosphate (ATP), the result is the production of one molecule of
adenosine monophosphate (AMP) (Kalckar, 1943). In order for a cell to maintain a
necessary level of energy for proper function, the ratio of ATP to AMP must remain high.
When reductions in the ratio occur, AMPK is activated. Reduced ATP:AMP is caused by
disruptions in the production of ATP, hypoxia or ischemia, and/or increases in the
consumption of ATP through muscle contraction (Kudo et al, 1995; Marsin et al, 2000;
Winder & Hardie, 1996). The phosphorylation of upstream kinases induces AMPK to
regulate cellular energy usage (Hawley et al, 1995). AMP regulates the activation of
AMPK and inhibits AMPK dephosphorylation by protein phosphatases (Hawley et al,
1995).
The activation of AMPK stimulates energy-conserving/producing pathways to
increase while simultaneously decreasing energy-consuming pathways. Previous research
suggests AMPK regulates VEGF in the skeletal muscle through the activation of p38
mitogen-activated protein kinase (MAPK) (Pages et al, 2000; Ouchi, Shibata, & Walsh,
2005; Winzen et al, 1999). AMPK also plays a role in the mediation of NO activity (Zhu
& Smart, 2005). Increased AMPK activity has been shown to increase VEGF mRNA
and VEGF protein, thereby increasing capillarization and the inactivation of AMPK
reduces capillarization at the basal level (Ouchi et al, 2005; Zwetsloot, Westerkamp,
Holmes & Gavin, 2008). However, AMPK activation is not necessary for aerobic

7
exercise-induced angiogenesis, but may play a role in response to resistance exercise
(Zwetsloot, Westerkamp, Holmes & Gavin, 2008).

Figure 1: Angiogenic Pathway in Response to Exercise.1Ouchi, Shibata & Walsh, 2005will not be investigated in this report 2Ziche et al, 1994; Isenberg et al, 2006-will not be
investigated in this report
Obesity
The skeletal muscle fiber size of obese individuals is markedly increased
compared to their lean counterparts (Gavin et al, 2005). VEGF is a necessary component
for muscle hypertrophy (Huey, Smith, Sulaeman & Breen, 2016), and basal regulation of
skeletal muscle VEGF and capillarization is altered by resting levels of AMPK
(Zwetsloot, Westerkamp, Holmes, & Gavin, 2008). However, resting levels of metabolic
and regulatory factors of angiogenesis are similar between lean and obese individuals of
similar physical inactivity. No differences at rest in AMPK, VEGF, or VEGFR2
expression have been found despite reduced capillary density and muscle fiber
hypertrophy observed in obese subjects (Gavin et al, 2005; Steinberg et al, 2004). Though
comparisons of basal TSP-1 in the skeletal muscle of lean and obese have not been
examined, elevated basal TSP-1 protein and gene expression in adipose tissue resulting in
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increased circulating TSP-1 in obese subjects has been noted (Abu-Farha, 2013; Hida et
al, 2000; Inoue et al, 2013; Varma et al, 2008; Voros et al, 2005).

Exercise and Angiogenesis
Aerobic Exercise
Angiogenesis in response to aerobic exercise in lean subjects has been well
researched. The interplay of angiogenic and angiostatic factors lead to an increase in
capillary density of the skeletal muscle following endurance training (Andersen &
Henriksson, 1977). Studies consistently report elevations in VEGF and VEGFR2
expression in the skeletal muscle in response to acute endurance exercise (Benoit et al,
1999; Gavin et al, 2005; Gustafsson et al, 2005; Ryan et al, 2006). Furthermore, TSP-1 is
temporarily increased following acute aerobic exercise, appearing to modulate capillary
formation (Hoier et al, 2012; Olfert et al, 2006; Olfert, Wagner, & Power, 2000). Cellular
energy usage is regulated through an increase of AMPK activity, heavily dependent upon
the duration and intensity of the exercise session (Fujii et al, 2000; Rasmussen & Winder,
1997; Stephens et al, 2002; Winder & Hardie, 1996; Wojtaszewski et al, 2000). AMPK is
not a necessary part of the angiogenic response to aerobic exercise (Zwetsloot,
Westerkamp, Holmes, & Gavin, 2008) but is one potential regulator of VEGF expression,
a key component for the muscle hypertrophic response to resistance exercise (Huey,
Smith, Sulaeman & Breen, 2016).
Resistance Exercise
There is very little research regarding the skeletal muscle angiogenic response
following resistance exercise. However, it is known that resistance training increases
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capillarization in the skeletal muscle in lean subjects (McCall et al, 1996; Schantz, 1982).
The increased capillarization is in proportion to the hypertrophy of the muscle fibers in
order to maintain the capillary density of the skeletal muscle (McCall et al, 1996;
Schantz, 1982). The angiogenic response to resistance exercise in terms of VEGF and
VEGFR2 expression is similar to that seen following aerobic exercise (Doyle & Haas,
2010; Huey, Smith, Sulaeman & Breen, 2016; Degens, Moore, & Alway, 2003; Gavin et
al, 2007; Parvaresh et al, 2010). Increases in VEGF mRNA are observed 2-3 h post
resistance exercise (Gavin et al, 2007; Silvennoinen et al, 2015) and VEGFR2 mRNA 4 h
post resistance exercise (Gavin et al, 2007). These increases in VEGF and VEGFR2
expression has been shown to play important roles in the maintenance of capillarization,
which is necessary for proper hypertrophy of the muscle (Huey, Smith, Sulaeman &
Breen, 2016). Elevated AMPK activity has also been noted in lean individuals during and
1 h following resistance exercise (Dreyer et al, 2006), indicating a potential role in
regulating VEGF production following resistance exercise. No investigations into TSP-1
expression in the skeletal muscle following resistance exercise have been published.

Obesity, Exercise, & Angiogenesis
Although no differences reside in basal levels of angiogenic factors between lean
and obese, obese demonstrate lower capillarization in the skeletal muscle (Gavin et al,
2005). An important stimulator of the angiogenic process is exercise (McCall et al, 1996;
Schantz, 1982). Few have reported any differences in the angiogenic response to aerobic
exercise between lean and obese individuals (Gavin et al, 2005; Walton et al, 2015).
AMPK activity in obese does not change while lean counterparts show an increase in
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AMPK activity following endurance exercise, suggesting an impaired response of AMPK
to aerobic exercise (Sriwijitkamol et al, 2007). However, VEGF and VEGFR2 expression
in response to aerobic exercise is similar between lean and obese individuals (Gavin et al,
2005). Levels of TSP-1, a potent angiostatic factor, in the adipose tissue of obese
individuals return to normal following acute exercise (Abu-Farha et al, 2013).
Although the hypertrophic response to resistance training is evident in obese
individuals (Donnelly et al, 1993; Geisler et al, 2011), researchers have not compared the
skeletal muscle angiogenic response following resistance exercise in lean and obese
individuals to date. The lack of differences in VEGF and VEGFR2 expression following
aerobic exercise, combined with the increased fiber diameter with subsequent decreased
capillarization (Gavin et al, 2005; McCall et al, 1996), suggests a decreased angiogenic
response to muscle hypertrophy in the skeletal muscle of obese individuals.

Hypothesis
At rest, obese subjects will have increased TSP-1 expression compared to lean
counterparts. Following acute resistance exercise, obese subjects will have: (i) lower
VEGF, VEGF receptor, and AMPK phosphorylation; and (ii) greater TSP-1 expression
compared to lean counterparts.
Delimitations
1. Participants were non-smoking and sedentary between the ages 18 and 35. Sedentary
specifies participating in physical activity 3 or fewer times per week for 20 minutes or
less. One group of individuals were lean with a body mass index (BMI) ≤ 25 kg/m2 while
the other group was classified as obese with a body mass index (BMI) ≥ 30 kg/m2.
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2. Workloads were tailored to each participant by first establishing their 1 repetition
maximum (1RM).
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CHAPTER 2. METHODS

The Purdue University Institutional Review Board approved the methods and protocol of
this study preceding its execution.

2.1

Participant Selection
Eight healthy, sedentary, lean (LN) individuals (4 women; 4 men) and eight

healthy, sedentary, obese (OB) individuals (4 women; 4 men) between the ages of 18-35
were recruited to participate in this study. Subjects were nonsmoking and had no known
chronic disease in order to be considered healthy enough to participate. Sedentary
qualifies as participating in physical activity 3 times or less for 20 minutes or fewer per
week. Lean individuals had a body mass index (BMI) < 25 kg/m2, while obese
individuals had a BMI ≥ 30 kg/m2. Qualified individuals were given both verbal and
written descriptions of the study. Subjects provided signed consent prior to the beginning
of the study, as well as completed an Activity and Tobacco Questionnaire and a Physical
Activity Readiness Questionnaire (PAR-Q). Subjects were given instructions on
completing a three day food intake diary for the days prior to the Day 2 procedures.
Subject characteristics are listed in Table 1.
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Table 1: Subject Characteristics. Values are listed as Mean ± SE. n = 8 subjects/group.
Lean

Obese

P Value

Age, yr

21.5 ± 0.5

24.8 ± 1.6

0.09

Height, cm

169.6 ± 2.9

172.8 ± 3.2

0.48

Mass, kg

62.4 ± 2.0

109.9 ± 7.8

<0.01

BMI

21.7 ± 0.8

36.6 ± 1.8

<0.01

VO2Max , ml O2/kg/min

37.3 ± 2.7

26.1 ± 2.7

0.01

1 RM, kg

27.8 ± 0.7

40.3 ± 4.7

0.03

1 RM, kg/kg

0.45 ± 0.01

0.37 ± 0.04

0.17

Fasting glucose, mM

4.8 ± 0.1

4.9 ± 0.2

0.54

Fasting insulin, µU/ml

11.8 ± 1.3

28.3 ± 4.8

0.01

Fasting HOMA-IR

2.46 ± 0.29

6.38 ± 1.23

0.01

Fasting HDL, mg/dl

58.4 ± 7.3

42.9 ± 5.4

0.08

Fasting LDL, mg/dl

88.6 ± 12.8

108.6 ± 5.2

0.11

Fasting Total Cholesterol, mg/dl

162.8 ± 12.3

180.6 ± 7.0

0.17

Fasting Triglycerides, mg/dl

79.4 ± 7.7

131.6 ± 22.5

0.05

2.2

Experimental Design
Day 1: Subjects reported to the Max E. Wastl Human Performance Laboratory

where their height, weight, and dominant leg was recorded prior to the completion of a
VO2MAX test. Subjects were then given a 15 minute rest period before the completion of a
one repetition maximum (1 RM) test for single leg, knee extension.
Maximal Oxygen Consumption (VO2MAX)
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Subject VO2MAX was determined two hours post-prandial using a previously
described incremental protocol (Kraus et al, 2004) on a cycle ergometer (Lode Excalibur
Sport, Groningen, The Netherlands). A warm up was performed at 50 W for 5 minutes on
the cycle ergometer. Immediately following, additional workloads were added every 2
minutes by 25 W until volitional fatigue. Expired air was monitored and recorded via
open-circuit spirometry (Truemax 2400, Parvo Metrics, Salt Lake City, UT).
Additionally, heart rate (model H1, Polar Electro, Lake Success, NY) and rate of
perceived exertion (RPE) was continuously monitored and recorded. Subjects were
verbally encouraged to continue as long as possible. Criteria for the establishment of
VO2MAX included 1) a heart rate of at least 90% of age predicted maximum (220-age); 2)
a respiratory exchange ratio (RER) at or above 1.10; and 3) an identifiable plateau (≤150
mL increase) in VO2 despite continued increase in workload. At least two of three criteria
were met for all subjects.
One Repetition Maximum (1RM)
Maximal knee extension was randomized between subjects using either the
dominant or non-dominant leg. Subjects began in a resting position of 90° and were
instructed to fully extend their leg undergoing the exercise using a weight of 13.6 kg.
Once parallel to the floor, they returned to the initial position and were given a rest for 1
minute. The exercise was repeated with weight increasing by 4.5 kg until the exercised
leg was no longer able to reach full extension. Once this point was attained, the previous
weight was determined to be the 1RM.
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Blood draw and
pre-exercise
biopsy

Leg extension
exercise

15 minute postexercise biopsy

3 hour postexercise biopsy

Figure 2: Day 2 timeline

Day 2: Day 2 occurred at least two weeks after Day 1. This was to avoid any
influence from the maximal testing incurred on Day 1 on the subjects’ performances on
Day 2. Three days preceding Day 2, subjects recorded their food intake and partook in a
12 h fast the night prior.
Blood draw
On the morning of Day 2, subjects reported to the Max E. Wastl Human
Performance Laboratory where a fasting blood draw was obtained. The 5-8 mL blood
sample was used for the measurement of glucose, insulin, high density lipoprotein
(HDL), low density lipoprotein (LDL), triglycerides, and total cholesterol. It was
collected in a serum tube, allowed for clot formation for 30 minutes at room temperature,
and then refrigerated until analysis by Mid-America Laboratories. Insulin resistance was
measured as HOMA-IR via the following equation:
HOMA-IR =

𝐹𝑆𝐺∗𝐹𝑆𝐼
22.5∗18

Fasting serum glucose (FSG) was used in milligrams per deciliter and fasting serum
insulin (FSI) was used in microunits per millimeter (Matthews et al, 1985).
Pre- and post-exercise muscle biopsies
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Immediately following the blood draw, the subjects underwent the procedure to
obtain the first (PRE) of three muscle biopsies. All biopsies were obtained from the
vastus lateralis: one biopsy before exercise from the non-working leg and two biopsies
from the working leg at 15 min post (15 MIN) and 3 h post (3 HR) exercise. The working
leg was randomized between non-dominant and dominant leg between subjects. On the
working leg, the two biopsy sites were separated by at least 3 cm (Costill, Pearson, &
Fink, 1988). Lidocaine (1%) was used as a local anesthetic to obtain the biopsy samples.
Tissue samples were immediately placed in liquid nitrogen and stored at -80°C for future
use.
Exercise protocol
Subjects performed three sets of knee extension exercise using their working leg
immediately following the first biopsy. Workload was set at 80% of their 1RM
determined on Day 1. 8-12 repetitions were performed for the first two sets and subjects
were instructed to perform to volitional fatigue for the last set (8-17 repetitions). A two
minute rest period was allotted between sets. Preliminary analysis found this protocol to
sufficiently fatigue the subjects and completion did not require any outside assistance.
Protein Isolation and Western Blot Analysis
Muscle biopsy samples were frozen in liquid nitrogen and homogenized in RIPA
buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 0.1% SDS, 0.1% Triton
X-100, and 0.5% Deoxycholate) with protease inhibitor cocktail and phosphatase
inhibitor (50 mM NaF and 0.2 mM Na3VO4). Samples were centrifuged at 4°C for 30
minutes to separate supernatant and insoluble material. The supernatant was used to
determine protein concentration by BCA kit (Pierce). Western blot analysis was
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performed in order to investigate angiogenic growth factor expression. Angiogenic
growth factors include VEGF and VEGF receptor (Gavin et al, 2005); and the antiangiogenic (angiostatic) factor include TSP-1 (Olfert et al, 2006). AMPK
phosphorylation was measured with exercise and obesity as AMPK is an important
regulator of VEGF (Zwetsloot, Westerkamp, Holmes, & Gavin, 2008).
Equal amounts of homogenized samples were added to 10% gels. Each membrane
was loaded with the 3 HR post exercise sample from subject 4 so that membranes could
be compared to one another. Membranes were then run through electrophoresis in
running buffer (0.1% SDS, 25 mM Tris, and 190 mM Glycine) at 80 V for 10 minutes, or
until proteins reached the end of the stacking gel, and then at 100-140 V for 1-2 hours.
Gels were transferred to PVDF membranes in transfer buffer (190 mM glycine 25 mM
Tris, and 20% Methanol) for 2 hours at 400 mA. Membranes were stained with Ponceau
in order to measure total protein loaded in each sample. After imaging, Ponceau was
rinsed from the membranes and then membranes were blocked with 5% non-fat milk
dissolved in TBST (25 mM Tris (pH 7.2), 150 mM NaCl, and 0.1% Tween 20) for 1 hour
at room temperature. Membranes were incubated with primary antibody (VEGF and
VEGFR2, Santa Cruz; AMPK, p-AMPK, and TSP-1 Cell Signaling Technology) in 5%
non-fat milk dissolved in TBST at 4°C overnight. Membranes were washed with TBST
for 10 minutes 3 times and then incubated in anti-rabbit or anti-mouse immunoglobulin
G-horseradish peroxidase (Cell Signaling Technology) or fluorescence (Li-COR)
conjugated secondary antibody for 1 hour. Membranes were again washed with TBST for
10 minutes 3 times and signals were visualized by fluorescence or chemiluminescence
under FluorChem E system (protein simple).
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Quantitative real-time PCR
RNA was isolated from muscle tissue samples using Trizol reagent (Invitrogen).
First-strand cDNA was generated by random hexamer primers with MMLV Reverse
Transcriptase (Invitrogen). Using a SYBR green PCR kit, the expression level of VEGF,
VEGFR2, and TSP-1 was determined by real-time PCR reactions in the Roche
LightCycler® 480 System (Roche). The internal control for gene expression was 18s
expression. The primer sequences are listed below:

Table 2: Primer sequences for gene expression
Gene Name

Forward (5’-3’)

Reverse (5’-3’)

VEGF

AGGGCAGAATCATCACGAAGT

AGGGTCTCGATTGGATGGCA

VEGFR2

GTGATCGGAAATGACACTGGAG

CATGTTGGTCACTAACAGAAGCA

TSP-1

AGACTCCGCATCGCAAAGG

TCACCACGTTGTTGTCAAGGG

18s

GGCCCTGTAATTGGAATGAGTC

CCAAGATCCAACTACGAGCTT

Statistical Analysis
Data were analyzed by use of a two-way (2 groups × 3 time points) mixedfactorial analysis of variance (ANOVA) test. Following a significant F ratio, Fisher’s
LSD post-hoc analysis was performed. Significance was established at α = 0.05 level and
data reported as Mean ± SE.
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CHAPTER 3. RESULTS

Subject Characteristics
Obese (OB) subjects had significantly greater body mass than lean (LN) subjects
(OB: 36.6 ± 1.8 kg/m2; LN: 21.7 ± 0.8 kg/m2). LN subjects demonstrated a significantly
higher VO2Max than OB (LN: 37.3 ± 2.7 ml O2/kg/min; OB: 26.1 ± 2.7 ml O2/kg/min).
OB demonstrated a higher 1 RM for single leg knee extension (LN: 27.8 ± 0.7 kg; OB:
40.3 ± 4.7 kg); however, when corrected for body mass, the difference was no longer
statistically significant (P = 0.17). No differences were observed in fasting glucose
between groups (LN: 4.8 ± 0.1 mM; OB: 4.9 ± 0.2 mM); however OB demonstrated a
higher fasting insulin (LN: 11.8 ± 1.3 µU/ml; OB: 28.3 ± 4.8 µU/ml) and fasting HOMAIR (LN: 2.46 ± 0.29; OB: 6.38 ± 1.23).

VEGF and VEGF receptor expression
The VEGF mRNA and protein responses to resistance exercise in LN and OB
subjects are displayed in Figure 3. Exercise significantly increased VEGF mRNA
similarly at 3 HR in both LN and OB subjects. There was no differences in VEGF protein
between LN and OB PRE, 15 MIN or 3 HR post exercise.
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Figure 3. Skeletal muscle vascular endothelial growth factor (VEGF) mRNA (a) protein
(b) and (c) western blot analysis in response to acute resistance exercise in LN and OB
individuals. VEGF mRNA was significantly increased at 3 HR. *Significantly different
from PRE (P ≤ 0.05). Mean ± SE. n = 8 subjects/group.
Skeletal muscle VEGFR2 mRNA and protein responses to exercise in LN and OB
individuals are displayed in Figure 4. No differences in the VEGFR2 mRNA or protein
were found between LN and OB individuals PRE, 15 MIN or 3 HR post exercise.
Exercise did not affect VEGFR2 mRNA or protein in either group.
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Figure 4. Skeletal muscle vascular endothelial growth factor receptor (VEGFR2) mRNA
(a) protein (b) and western blot analysis (c) in response to acute resistance exercise in LN
and OB individuals. Mean ± SE. n = 8 subjects/group.
TSP-1 expression
Skeletal muscle TSP-1 mRNA and protein responses to exercise in LN and OB
individuals are displayed in Figure 5. There were no differences in TSP-1 mRNA
between LN and OB at any time point and no effect of exercise. Similarly, there was no
effect of obesity or exercise on TSP-1 protein expression.
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Figure 5. Skeletal muscle thrombospondin-1 (TSP-1) mRNA (a) protein (b) and western
blot analysis (c) in response to acute resistance exercise in LN and OB individuals.

AMPK and p-AMPK expression
Skeletal muscle AMPK and p-AMPK protein responses to exercise in LN and OB
individuals are displayed in Figure 6. Exercise and obesity had no effect on p-AMPK,
pan-AMPK, or the p-AMPK/pan-AMPK ratio PRE, 15 MIN or 3 HR post exercise.
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Figure 6. Skeletal muscle 5’ AMP-activated protein kinase (AMPK) protein (a),
phosphorylated AMPK (p-AMPK) protein (b) p-AMPK/AMPK protein (c) and western
blot analysis (d) in response to acute resistance exercise in LN and OB individuals. Mean
± SE. n = 8 subjects/group.
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CHAPTER 4. DISCUSSION

The principal findings of the current study are there were no differences in the
expression of VEGF, VEGF receptor and TSP-1 at rest and following acute resistance
exercise between lean and obese groups. Consistent with previous work, resistance
exercise did increase VEGF mRNA in both lean and obese individuals. In addition, there
was no difference at rest or in response to exercise in AMPK between lean and obese
groups and acute resistance exercise did not increase the phosphorylation of AMPK in
either group 15 MIN or 3 HR post exercise.

Obesity and basal VEGF and VEGF receptor expression
Similar basal levels of VEGF and VEGF receptor mRNA between the skeletal
muscle of lean and obese individuals have been previously reported (Gavin et al, 2005).
No there was no difference in the VEGF and VEGF receptor protein content of the
skeletal muscle of lean and obese individuals (Gavin et al, 2005). Our data further
support the notion that VEGF and VEGF receptor mRNA and protein expression are
similar between lean and obese individuals at rest.
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Obesity, exercise and VEGF and VEGF receptor expression
The current report utilizes a single bout of resistance exercise, a stimulus of
muscle hypertrophy when repeated, in order to investigate the reduced capillary density
observed with basal hypertrophy seen in obese individuals. Investigations using animal
models suggest the skeletal muscle of obese have the ability to hypertrophy but have a
decreased response to functional overload, a model for resistance exercise, compared to
lean (Katta et al, 1985; Paturi et al, 2010). Similarly, Donnelly and colleagues showed an
increased hypertrophy with resistance exercise in obese subjects but did not compare
these results to lean counterparts (Donnelly et al, 1993). Therefore, this could result in
lesser angiogenesis in obese individuals compared to lean due to less activation of
hypertrophic pathways.
Very little research regarding the angiogenic response to resistance exercise in
lean individuals has been conducted. Previous investigations show elevations in VEGF
mRNA as early as 1 h following the completion of acute resistance exercise in lean
individuals (Gavin et al 2007; Silvennoinen et al, 2015; Trenerry et al, 2007). Increases in
VEGF mRNA >2.5 fold have been reported in human subjects (Gavin et al, 2007). This
is relatively similar to what is shown in the present study, demonstrating an increase of
~2.2 fold 3 h post exercise. VEGF protein expression did not change following exercise,
and no differences were found between lean and obese subjects. The present findings are
in contrast to a previous report of increased VEGF protein expression by ~15% 2 h post
resistance in lean individuals (Gavin et al, 2007). However, differences in analysis
techniques could account for the variations, as Gavin and colleagues used ELISA for
analysis which is thought to be more sensitive than Western Blot techniques (Kuijf et al,
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2009). Further investigations are needed in order to develop an accurate time course of
VEGF protein expression in the skeletal muscle following resistance exercise.
Increases in VEGF receptor mRNA have been observed at 4 h but not 2 h post
resistance exercise in lean individuals (Gavin et al, 2007). Considering other factors
involved in the present study, 3 h was chosen for the final biopsy with the hopes this
would be sufficient time for changes in VEGF receptor mRNA to occur. The present
study shows no increase in VEGF receptor mRNA in lean or obese individuals up to 3 h
following resistance exercise. Similarly, exercise did not increase skeletal muscle VEGF
receptor protein expression in lean or obese subjects. Gavin and colleagues also showed
no changes in VEGF receptor protein expression 4 h post resistance exercise in lean
individuals, as expected since protein changes occur after mRNA changes (Gavin et al,
2004). However, VEGF receptor protein expression increases have been observed 6
hours post aerobic exercise (Gustafsson et al, 2005). Since little is known about other
factors involved in this study, a 6 h instead of 3 h post biopsy could have resulted in
potentially missing important changes immediately following the acute resistance
exercise bout. The last skeletal muscle biopsy was obtained 3 h post exercise in the
present study. Therefore, 3 h may be insufficient to observe changes in VEGF receptor
mRNA or protein expression following acute resistance exercise.

Obesity and basal TSP-1 expression
TSP-1 is an angiostatic factor that is present in several tissues and is involved in
cell adhesion, migration, and growth factor regulation (Lawler, 2002; Roberts, 1996;
Sage & Bornstein, 1991). Comparisons of TSP-1 levels between lean and obese have
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previously been investigated in the adipose tissue, as dynamic alterations in the
extracellular matrix are required during the expansion of adipose tissue (Kong, Cavalera
& Frangogiannis, 2014; Sun, Kusminski & Scherer, 2011). Vascularization and adipose
tissue development are coupled from early development throughout adult life (Cranell,
Hausman & Kral, 1997) Adipocytes play an important role in guiding and maintaining
microvessel growth (Lau, 1990; Lau et al, 1990) and are a major site of TSP-1 secretion
(Varma et al, 2008). Animal models demonstrate the lack of TSP-1 or its receptors as a
protective mechanism against the development of obesity (Frazier et al, 2011; Kong et al,
2013; Maimaitiyiming et al, 2015). However, it has also been proposed that TSP-1
deficiency only improves glucose tolerance and increases insulin sensitivity with no
effect on the development of obesity (Li et al, 2011). TSP-1 mRNA expression in the
adipose tissue of human subjects suggests a positive correlation between TSP-1
expressed in the visceral adipose tissue and BMI (Matsuo et al, 2015; Varma et al, 2008).
Evidence of increased TSP-1 expression in obese is also observed in other organs such as
the heart (Gonzalez-Quesada et al, 2013) and blood vessels (Stenina et al, 2003).
To our knowledge, no previous studies have reported basal levels of TSP-1
expressed in the skeletal muscle of lean compared to obese individuals. Chronic delivery
of TSP-1 to the skeletal muscle reduces capillarity, as shown in mouse models (Audet,
Fulks, Stricker & Olfert, 2013). However, results of the present study show no
differences in basal skeletal muscle TSP-1 mRNA despite significant differences in BMI.
Therefore, another angiostatic factor may be responsible for the reduced capillary density
present in the skeletal muscle of obese individuals.

28
Obesity, exercise and TSP-1 expression
Investigations of TSP-1 mRNA expression following exercise have been reported
with lean subjects. In Wistar rats, TSP-1 mRNA expression is increased 3.5 fold
immediately following aerobic exercise, with further elevations 1 h post exercise before
returning to baseline (Olfert, Breen, Gavin & Wagner, 2009). Three days of aerobic
training attenuates this increase while the acute response is restored following 8 wks of
training (Olfert, Breen, Gavin & Wagner, 2009). TSP-1 mRNA demonstrates a similar
response to aerobic exercise in lean human subjects (Hoier et al, 2012). The current study
is the first to investigate the TSP-1 mRNA and protein expression following acute
resistance exercise in lean and obese subjects.
Aerobic exercise increases AMPK activity and TSP-1 expression at similar time
points, within 2 h post exercise (Hoier et al, 2012; Olfert, Breen, Gavin & Wagner, 2009;
Olfert et al, 2006; Olfert, Wagner, & Power, 2000; Sriwijitkamol et al, 2007; Stephens et
al, 2002); however the present study shows no increase in AMPK phosphorylation or
TSP-1 expression following resistance exercise. Though a negative finding, this is
consistent with TSP-1 expression regulation by AMPK. Further investigation into
skeletal muscle TSP-1 expression following exercise may be beneficial in order to
investigate potential regulators of TSP-1 and establish an accurate time course of
response.

Obesity and basal p-AMPK and AMPK expression
The phosphorylation of AMPK regulates cellular energy usage by increasing the
activity of energy conserving pathways while concurrently reducing the activity of
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energy consuming pathways (Hawley et al, 1995). In obese Zucker rats, basal levels of
skeletal muscle AMPK phosphorylation and the subsequent p-AMPK:AMPK ratio are
significantly higher than their lean counterparts (Chen, Lee, Kuo & Ho, 2011). Other
investigations, including the present study, have found no effect of obesity on basal
AMPK activity (Lee-Young et al, 2011; Steinberg et al, 2004). Differences between
human and animal models could in part account for the conflicting results. More
investigation into the basal activity of AMPK between lean and obese, especially in
human subjects, is needed.

Obesity, exercise and p-AMPK and AMPK expression
AMPK is an important regulator of the body’s response to stressors. One
important stressor known to increase AMPK activity is exercise (Winder & Hardie,
1996). Mouse models have demonstrated that diet-induced obesity has a negative impact
on AMPK activity in response to acute aerobic exercise (Lee-Young et al, 2011). Similar
results have been shown in human studies involving moderate intensity aerobic exercise
in obese subjects (Sriwijitkamol et al, 2007). In contrast, lean and obese Zucker rats show
no difference in the activation of AMPK following 6 wks of aerobic exercise training
(Chen, Lee, Kuo & Ho, 2011). However, obese Zucker rats have significantly lower
AMPK phosphorylation following exercise training, while lean Zucker rats show no
change (Chen, Lee, Kuo & Ho, 2011). This suggests aerobic exercise training could
restore the AMPK response of obese subjects.
Investigations into AMPK activity in response to resistance exercise in lean
individuals demonstrate conflicting results (Ahtiainen et al, 2015; Apro et al, 2015;

30
Dreyer et al, 2006; Silvennoinen et al, 2015). However, the phosphorylation of AMPK
appears to be resistance exercise volume-dependent. Ahtiainen and colleagues observed
an increased p-AMPK protein expression 30 min following 10 but not 5 sets of 10 RM
using a leg press device (Ahtiainen et al, 2015). Previous reports suggest AMPK activity
is increased within the first 30 min of exercise (Dreyer et al, 2006; Silvennoinen et al,
2015). The present study observed no changes in p-AMPK following 3 sets of knee
extension. Therefore, the volume of the current exercise bout may have been insufficient
to elicit a response since samples were obtained within the suggested time window.
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Limitations
As with all studies, limitations to the experimental design are present in the
current report. Participants were both male and female and the menstrual cycle of female
subjects were not controlled for. Hormonal differences could impact the skeletal muscle
and therefore could result in increases variability within the results. Participants
documented, but did not alter, their diet in this experiment. Subjects were asked to eat
normally and record all food and beverage intake for three days preceding Day 2. Hours
of sleep prior to Day 2 procedure were not controlled. At least two weeks separated Days
1 and 2; however the number of days between varied between subjects due to scheduling
availability. Baseline biopsies were obtained from the non-working leg to avoid three
biopsies on one single leg. Time of biopsies attempted to capture changes in muscle
mRNA and proteins with limited information on their time courses following resistance
exercise. Therefore, potential changes could have been missed. Due to limited
information on the angiogenic response following resistance exercise, duration and
intensity of the exercise bout may have been insufficient to produce changes.
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Future Directions
The increased VEGF expression reported in the current study further supports
findings that resistance exercise training can elicit angiogenesis, though there is no
difference between lean and obese individuals. However, the skeletal muscle of obese
individuals is unable to maintain capillary density with muscle hypertrophy. It would be
beneficial to study the long term angiogenic response to high volume resistance training
in obese individuals, as there appears to be a disruption between the acute response and
the development of capillaries. Other possible angiostatic factors that could be hindering
capillary formation should be investigated.
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CHAPTER 5. CONCLUSION

In summary, the present study demonstrates that lean and obese individuals have
a similar angiogenic response to acute resistance exercise. Future studies are needed in
order to observe the effect of repeated bouts of resistance exercise on skeletal muscle
angiogenesis between lean and obese individuals. Considerations into possible angiostatic
factors other than TSP-1 contributing to reduced angiogenesis should be investigated.
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